More countries pause AstraZeneca vaccine
A day after European regulators described a “possible link” between AstraZeneca’s vaccine and rare blood clots, the vaccine faced increasing hurdles as countries around the world moved to restrict its use in younger people. South Korean officials said they would decide this weekend whether to resume administering the shot to people 60 and younger. Others, including the Democratic Republic of Congo, Denmark and Norway, have suspended use of the vaccine altogether until more information about the clotting risk is available. Health officials in the Netherlands, Spain and Portugal are also limiting the AstraZeneca vaccine to people